Page 1730 - Williams Hematology ( PDFDrive )

1704 Part XI: Malignant Lymphoid Diseases Chapter 104: Mature T-Cell and Natural Killer Cell Lymphomas 1705

117. Di Sabatino A, Biagi F, Gobbi PG, et al: How I treat enteropathy-associated T-cell lym- 149. Takemoto S, Matsuoka M, Yamaguchi K, et al: A novel diagnostic method of adult T-cell
phoma. Blood 119:2458–2468, 2012. leukemia: Monoclonal integration of human T-cell lymphotropic virus type I provirus
118. Catassi C, Bearzi I, Holmes GK: Association of celiac disease and intestinal lymphomas DNA detected by inverse polymerase chain reaction. Blood 84:3080–3085, 1994.
and other cancers. Gastroenterology 128:S79–S86, 2005. 150. Lorand-Metze I, Pombo-de-Oliveira MS: Adult T-cell leukemia (ATL) with an unusual
119. Deleeuw RJ, Zettl A, Klinker E, et al: Whole-genome analysis and HLA genotyping of immunophenotype and a high cellular proliferation rate. Leuk Lymphoma 22:523–526, 1996.
enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroente rology 151. Flug F, Pelicci PG, Bonetti F, et al: T-cell receptor gene rearrangements as markers of
132:1902–1911, 2007. lineage and clonality in T-cell neoplasms. Proc Natl Acad Sci U S A 82:3460–3464, 1985.
120. Sieniawski M, Angamuthu N, Boyd K, et al: Evaluation of enteropathy-associated T-cell 152. Bertness V, Kirsch I, Hollis G, et al: T-cell receptor gene rearrangements as clinical
lymphoma comparing standard therapies with a novel regimen including autologous markers of human T-cell lymphomas. N Engl J Med 313:534–538, 1985.
stem cell transplantation. Blood 115:3664–3670, 2010. 153. Waldmann TA, Davis MM, Bongiovanni KF, et al: Rearrangements of genes for the
121. Gale J, Simmonds PD, Mead GM, et al: Enteropathy-type intestinal T-cell lymphoma: antigen receptor on T cells as markers of lineage and clonality in human lymphoid
Clinical features and treatment of 31 patients in a single center. J Clin Oncol 18:795– neoplasms. N Engl J Med 313:776–783, 1985.
803, 2000. 154. Yamada Y, Tomonaga M, Fukuda H, et al: A new G-CSF-supported combination che-
122. Rohatiner A, d’Amore F, Coiffier B, et al: Report on a workshop convened to discuss the motherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology
pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol Group Study 9303. Br J Haematol 113:375–382, 2001.
5:397–400, 1994. 155. Tsukasaki K, Utsunomiya A, Fukuda H, et al: VCAP-AMP-VECP compared with
123. Domizio P, Owen RA, Shepherd NA, et al: Primary lymphoma of the small intestine. A biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group
clinicopathological study of 119 cases. Am J Surg Pathol 17:429–442, 1993. Study JCOG9801. J Clin Oncol 25:5458–5464, 2007.
124. Bagdi E, Diss TC, Munson P, et al: Mucosal intra-epithelial lymphocytes in enteropathy- 156. Bazarbachi A, Plumelle Y, Carlos Ramos J, et al: Meta-analysis on the use of zidovudine
associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in
a neoplastic population. Blood 94:260–264, 1999. the leukemic subtypes. J Clin Oncol 28:4177–4183, 2010.
125. de Bruin PC, Connolly CE, Oudejans JJ, et al: Enteropathy-associated T-cell lympho- 157. Ishida T, Joh T, Uike N, et al: Defucosylated anti-CCR4 monoclonal antibody (KW-
mas have a cytotoxic T-cell phenotype. Histopathology 31:313–317, 1997. 0761) for relapsed adult T-cell leukemia-lymphoma: A multicenter phase II study. J Clin
126. Wohrer S, Chott A, Drach J, et al: Chemotherapy with cyclophosphamide, doxoru- Oncol 30:837–842, 2012.
bicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with 158. Jo T, Ishida T, Takemoto S, et al: Randomized phase II study of mogamulizumab (KW-
enteropathy-type intestinal T-cell lymphoma. Ann Oncol 15:1680–1683, 2004. 0761) plus VCAP-AMP-VECP (mLSG15) versus mLSG15 alone for newly diagnosed
127. Bishton MJ, Haynes AP: Combination chemotherapy followed by autologous stem cell aggressive adult T-cell leukemia-lymphoma (ATL). J Clin Oncol 31, 2013.
transplant for enteropathy-associated T cell lymphoma. Br J Haematol 136:111–113, 2007. 159. Hishizawa M, Kanda J, Utsunomiya A, et al: Transplantation of allogeneic hemato-
128. Jantunen E, Juvonen E, Wiklund T, et al: High-dose therapy supported by autologous poietic stem cells for adult T-cell leukemia: A nationwide retrospective study. Blood
stem cell transplantation in patients with enteropathy-associated T-cell lymphoma. 116:1369–1376, 2010.
Leuk Lymphoma 44:2163–2164, 2003. 160. Phillips AA, Willim RD, Savage DG, et al: A multi-institutional experience of autol-
129. Daum S, Ullrich R, Heise W, et al: Intestinal non-Hodgkin’s lymphoma: A multicenter ogous stem cell transplantation in North American patients with human T-cell lym-
prospective clinical study from the German Study Group on Intestinal non-Hodgkin’s photropic virus type-1 adult T-cell leukemia/lymphoma suggests ineffective salvage of
Lymphoma. J Clin Oncol 21:2740–2746, 2003. relapsed patients. Leuk Lymphoma 50:1039–1042, 2009.
130. Uchiyama T, Yodoi J, Sagawa K, et al: Adult T-cell leukemia: Clinical and hematologic 161. Tsukasaki K, Maeda T, Arimura K, et al: Poor outcome of autologous stem cell trans-
features of 16 cases. Blood 50:481–492, 1977. plantation for adult T cell leukemia/lymphoma: A case report and review of the litera-
131. Bunn PA Jr, Schechter GP, Jaffe E, et al: Clinical course of retrovirus-associated adult ture. Bone Marrow Transplant 23:87–89, 1999.
T-cell lymphoma in the United States. N Engl J Med 309:257–264, 1983. 162. Falchook GS, Vega F, Dang NH, et al: Hepatosplenic gamma-delta T-cell lymphoma:
132. Waldmann TA, Greene WC, Sarin PS, et al: Functional and phenotypic comparison of Clinicopathological features and treatment. Ann Oncol 20:1080–1085, 2009.
human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T 163. Weidmann E: Hepatosplenic T cell lymphoma. A review on 45 cases since the first report
cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using describing the disease as a distinct lymphoma entity in 1990. Leukemia 14:991–997, 2000.
anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor. 164. Clarke CA, Morton LM, Lynch C, et al: Risk of lymphoma subtypes after solid organ
J Clin Invest 73:1711–1718, 1984. transplantation in the United States. Br J Cancer 109:280–288, 2013.
133. Shimoyama M: Diagnostic criteria and classification of clinical subtypes of adult T-cell 165. Mason M, Siegel CA: Do inflammatory bowel disease therapies cause cancer? Inflamm
leukaemia-lymphoma. A report from the Lymphoma Study Group (1984–87). Br J Bowel Dis 19:1306–1321, 2013.
Haematol 79:428–437, 1991. 166. Farcet JP, Gaulard P, Marolleau JP, et al: Hepatosplenic T-cell lymphoma: Sinusal/sinu-
134. Yamamoto JF, Goodman MT: Patterns of leukemia incidence in the United States soidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood
by subtype and demographic characteristics, 1997–2002. Cancer Causes Control 75:2213–2219, 1990.
19:379–390, 2008. 167. Jonveaux P, Daniel MT, Martel V, et al: Isochromosome 7q and trisomy 8 are consistent
135. Abbaszadegan MR, Gholamin M, Tabatabaee A, et al: Prevalence of human T-lym- primary, non-random chromosomal abnormalities associated with hepatosplenic T
photropic virus type 1 among blood donors from Mashhad, Iran. J Clin Microbiol gamma/delta lymphoma. Leukemia 10:1453–1455, 1996.
41:2593–2595, 2003. 168. Wang CC, Tien HF, Lin MT, et al: Consistent presence of isochromosome 7q in hepato-
136. Paun L, Ispas O, Del Mistro A, et al: HTLV-I in Romania. Eur J Haematol 52:117–118, splenic T gamma/delta lymphoma: A new cytogenetic-clinicopathologic entity. Genes
1994. Chromosomes Cancer 12:161–164, 1995.
137. Gessain A, Cassar O: Epidemiological aspects and world distribution of HTLV-1 infection. 169. Kanavaros P, Farcet JP, Gaulard P, et al: Recombinative events of the T cell antigen
Front Microbiol 3:388, 2012. receptor delta gene in peripheral T cell lymphomas. J Clin Invest 87:666–672, 1991.
138. Mahieux R, Gessain A: Adult T-cell leukemia/lymphoma and HTLV-1. Curr Hematol 170. Belhadj K, Reyes F, Farcet JP, et al: Hepatosplenic gammadelta T-cell lymphoma is a rare
Malig Rep 2:257–264, 2007. clinicopathologic entity with poor outcome: Report on a series of 21 patients. Blood
139. Kaplan J, Khabbaz R: The epidemiology of human T-lymphotropic virus types I and II. 102:4261–4269, 2003.
Rev Med Virol 3:137–148, 1993. 171. Voss MH, Lunning MA, Maragulia JC, et al: Intensive induction chemotherapy fol-
140. Franchini G, Nicot C, Johnson JM: Seizing of T cells by human T-cell leukemia/lym- lowed by early high-dose therapy and hematopoietic stem cell transplantation results in
phoma virus type 1. Adv Cancer Res 89:69–132, 2003. improved outcome for patients with hepatosplenic T-cell lymphoma: A single institu-
141. Cleghorn FR, Manns A, Falk R, et al: Effect of human T-lymphotropic virus type I infec- tion experience. Clin Lymphoma Myeloma Leuk 13:8–14, 2013.
tion on non-Hodgkin’s lymphoma incidence. J Natl Cancer Inst 87:1009–1014, 1995. 172. Tey SK, Marlton PV, Hawley CM, et al: Post-transplant hepatosplenic T-cell lymphoma
142. Suzumiya J, Ohshima K, Tamura K, et al: The International Prognostic Index predicts successfully treated with HyperCVAD regimen. Am J Hematol 83:330–333, 2008.
outcome in aggressive adult T-cell leukemia/lymphoma: Analysis of 126 patients from 173. Corazzelli G, Capobianco G, Russo F, et al: Pentostatin (2’-deoxycoformycin) for the
the International Peripheral T-Cell Lymphoma Project. Ann Oncol 20:715–721, 2009. treatment of hepatosplenic gammadelta T-cell lymphomas. Haematologica 90:ECR14,
143. Bazarbachi A, Suarez F, Fields P, et al: How I treat adult T-cell leukemia/lymphoma. 2005.
Blood 118:1736–1745, 2011. 174. Cheung MM, Chan JK, Wong KF: Natural killer cell neoplasms: A distinctive group of
144. Oshiro A, Tagawa H, Ohshima K, et al: Identification of subtype-specific genomic highly aggressive lymphomas/leukemias. Semin Hematol 40:221–232, 2003.
alterations in aggressive adult T-cell leukemia/lymphoma. Blood 107:4500–4507, 2006. 175. Chan JK: Natural killer cell neoplasms. Anat Pathol 3:77–145, 1998.
145. Takasaki Y, Iwanaga M, Imaizumi Y, et al: Long-term study of indolent adult T-cell 176. Liang X, Graham DK: Natural killer cell neoplasms. Cancer 112:1425–1436, 2008.
leukemia-lymphoma. Blood 115:4337–4343, 2010. 177. Kwong YL: Natural killer-cell malignancies: Diagnosis and treatment. Leukemia 19:
146. Moriyama K, Muranishi H, Nishimura J, et al: Immunodeficiency in preclinical smol- 2186–2194, 2005.
dering adult T-cell leukemia. Jpn J Clin Oncol 18:363–369, 1988. 178. Aviles A, Diaz NR, Neri N, et al: Angiocentric nasal T/natural killer cell lymphoma: A
147. Takatsuki F YK, Hattori T.. Adult T-cell leukemia/lymphoma. In:, (ed. Retrovirus Biol- single centre study of prognostic factors in 108 patients. Clin Lab Haematol 22:215–220,
ogy and Human Disease, edited by Robert C Gallo and Flossie Wong-Staal, pp 147–159. 2000.
Marcel Dekker, New York, 1990:. 179. Barrionuevo C, Zaharia M, Martinez MT, et al: Extranodal NK/T-cell lymphoma, nasal
148. Amagasaki T, Tomonaga Y, Yamada Y, et al: Adult T-cell leukemia with an unusual type: Study of clinicopathologic and prognosis factors in a series of 78 cases from Peru.
phenotype, Leu-2a positive and Leu-3a negative. Blut 50:209–211, 1985. Appl Immunohistochem Mol Morphol 15:38–44, 2007.

Kaushansky_chapter 104_p1693-1706.indd 1705 9/21/15 12:48 PM